Skip to main content
Full access
Published Date: 17 May 2019

Front Matter

Publication: Bipolar II Disorder: Recognition, Understanding, and Treatment
BIPOLAR II DISORDER
RECOGNITION, UNDERSTANDING, AND TREATMENT
BIPOLAR II DISORDER
RECOGNITION, UNDERSTANDING, AND TREATMENT
Edited by
Holly A. Swartz, M.D.
Trisha Suppes, M.D., Ph.D.
Note: The authors have worked to ensure that all information in this book is accurate at the time of publication and consistent with general psychiatric and medical standards, and that information concerning drug dosages, schedules, and routes of administration is accurate at the time of publication and consistent with standards set by the U.S. Food and Drug Administration and the general medical community. As medical research and practice continue to advance, however, therapeutic standards may change. Moreover, specific situations may require a specific therapeutic response not included in this book. For these reasons and because human and mechanical errors sometimes occur, we recommend that readers follow the advice of physicians directly involved in their care or the care of a member of their family.
Books published by American Psychiatric Association Publishing represent the findings, conclusions, and views of the individual authors and do not necessarily represent the policies and opinions of American Psychiatric Association Publishing or the American Psychiatric Association.
If you wish to buy 50 or more copies of the same title, please go to www.appi.org/specialdiscounts for more information.
Copyright © 2019 American Psychiatric Association Publishing
ALL RIGHTS RESERVED
First Edition
Manufactured in the United States of America on acid-free paper
23 22 21 20 19  5 4 3 2 1
American Psychiatric Association Publishing
800 Maine Avenue SW
Suite 900 Washington, DC 20024-2812
Library of Congress Cataloguing-in-Publication Data
Names: Swartz, Holly A., editor. | Suppes, Trisha, editor. | American Psychiatric Association Publishing, issuing body.
Title: Bipolar II disorder : recognition, understanding, and treatment / edited by Holly A. Swartz, Trisha Suppes.
Other titles: Bipolar II disorder (Swartz)
Description: First edition. | Washington, D.C. : American Psychiatric Association Publishing, [2019] | Includes bibliographical references and index. |
Identifiers: LCCN 2019011723 (print) | LCCN 2019012924 (ebook) | ISBN 9781615372591 () | ISBN 9781615371785 (pbk. : alk. paper)
Subjects: | MESH: Bipolar Disorder—diagnosis | Bipolar Disorder—therapy
Classification: LCC RC516 (ebook) | LCC RC516 (print) | NLM WM 171.7 | DDC 616.89/5—dc23
LC record available at https://lccn.loc.gov/2019011723
British Library Cataloguing in Publication Data
A CIP record is available from the British Library.
To Steven, Sophie, and Eli—each special, for different reasons.
H.A.S.
To my sisters and brothers Deborah, John, Alexandra, and Michael with great appreciation you are in my life.
T.S.
To our patients and colleagues who taught us about bipolar II disorder; you made this book possible.

Contents

Contributors
Preface
Holly A. Swartz, M.D., and Trisha Suppes, M.D., Ph.D.
Part I
Recognition
1 A Neglected Condition
Holly A. Swartz, M.D., and Trisha Suppes, M.D., Ph.D.
2 Diagnosing Bipolar II Disorder
Nicole Kramer, M.A., M.S., and Trisha Suppes, M.D., Ph.D.
3 Interface Between Borderline Personality Disorder and Bipolar II Disorder
Mark Zimmerman, M.D., and Theresa A. Morgan, Ph.D.
4 Psychiatric and Medical Comorbidities With Bipolar II Disorder
Joshua D. Rosenblat, M.D., Michael J. Ostacher, M.D., M.P.H., M.M.Sc., and Roger S. McIntyre, M.D., F.R.C.P.C.
5 Suicide and Bipolar II Disorder
Ayal Schaffer, M.D., F.R.C.P.C., and
Mark Sinyor, M.Sc., M.D., F.R.C.P.C.
Part II
Understanding
6 Genetics of Bipolar II Disorder
Melvin McInnis, M.D.
7 Functional Brain Imaging and Neural Determinants in Bipolar II Disorder
Anna Manelis, Ph.D., Adriane M. Soehner, Ph.D., and
Mary L. Phillips, M.D., M.D.(Cantab.)
Part III
Treatment
8 Mood Stabilizers and Antipsychotic Medications in Bipolar II Disorder
Eva Solé, M.D., Marina Garriga, M.D., and
Eduard Vieta, M.D., Ph.D.
9 Antidepressant Medications in Bipolar II Disorder
Susan L. McElroy, M.D., and Alex Israel, M.D.
10 Psychosocial Interventions in Bipolar II Disorder
Danielle M. Novick, Ph.D., and Holly A. Swartz, M.D.
Part IV
Special Populations
11 Bipolar II Disorder in Childhood and Adolescence
Manivel Rengasamy, M.D., and Boris Birmaher, M.D.
12 Reproductive-Age Women With Bipolar II Disorder
Eydie L. Moses-Kolko, M.D., Crystal T. Clark, M.D., M.Sc.,
Sarah DeBrunner, M.D., and Katherine L. Wisner, M.D., M.S.
Index

Contributors

Boris Birmaher, M.D.
Professor of Psychiatry and Endowed Chair in Early Bipolar Disorder, Director of the Child and Adolescent Bipolar Services Program, Co-Director of Psychiatry Research Pathway Program, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Crystal T. Clark, M.D., M.Sc.
Assistant Professor of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Asher Center for the Study and Treatment of Depressive Disorders, Northwestern Feinberg School of Medicine, Chicago, Illinois
Sarah DeBrunner, M.D.
Clinical Assistant Professor, University of Pittsburgh School of Medicine, Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
Marina Garriga, M.D.
Psychiatrist, Department of Psychiatry and Psychology, Institute of Neuroscience, University of Barcelona, Hospital Clinic, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
Alex Israel, M.D.
Graduate Medical Resident in Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania
Nicole Kramer, M.A., M.S.
Doctoral Candidate and Research Assistant, Prevention and Intervention Laboratory, Stanford University School of Medicine, Stanford, California
Anna Manelis, Ph.D.
Assistant Professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Susan L. McElroy, M.D.
Chief Research Officer, Lindner Center of HOPE, Mason, Ohio; Professor of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio
Melvin McInnis, M.D.
Thomas B. and Nancy Upjohn Woodworth Professor of Bipolar Disorder and Depression, Professor of Psychiatry, University of Michigan Medical School, Ann Arbor, Michigan
Roger S. McIntyre, M.D., F.R.C.P.C.
Professor of Psychiatry and Pharmacology, University of Toronto; University Health Network, Mood Disorder Psychopharmacology Unit (MDPU), Toronto, ON, Canada
Theresa A. Morgan, Ph.D.
Clinical Assistant Professor of Psychiatry, Brown University; Staff Psychologist, Rhode Island Hospital, Providence, Rhode Island
Eydie L. Moses-Kolko, M.D.
Associate Professor of Psychiatry, University of Pittsburgh School of Medicine, Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
Danielle M. Novick, Ph.D.
Clinical Psychologist, Outpatient Mood Disorders Clinic, Clinical Supervisor, Clinical Training Committee, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania
Michael J. Ostacher, M.D., M.P.H., M.M.Sc.
Associate Professor of Psychiatry, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine; Medical Director, VA/Stanford Bipolar and Depression Research Program, Veterans Affairs Palo Alto Health Care System, Palo Alto, California
Mary L. Phillips, M.D., M.D.(Cantab.)
Pittsburgh Foundation-Emmerling Endowed Chair in Psychotic Disorders, Professor in Psychiatry and Clinical and Translational Science, and Director of the Mood and Brain Laboratory, The Clinical and Translational Affective Neuroscience Program, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Manivel Rengasamy, M.D.
Child Psychiatry Fellow, Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
Joshua D. Rosenblat, M.D.
Chief Resident of Psychiatry, Clinician Scientist Program, University of Toronto; University Health Network, Mood Disorder Psychopharmacology Unit (MDPU), Toronto, ON, Canada
Ayal Schaffer, M.D., F.R.C.P.C.
Deputy Psychiatrist-in-Chief, Head, Mood and Anxiety Disorders Program, Sunnybrook Health Sciences Centre; Professor, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
Mark Sinyor, M.Sc., M.D., F.R.C.P.C.
Psychiatrist, Sunnybrook Health Sciences Centre; Assistant Professor, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
Adriane M. Soehner, Ph.D.
Assistant Professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Eva Solé, M.D.
Psychiatrist, Department of Psychiatry and Psychology, Institute of Neuroscience, University of Barcelona, Hospital Clinic, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
Trisha Suppes, M.D., Ph.D.
Professor, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California; VA Palo Alto Health Care System, Palo Alto, California
Holly A. Swartz, M.D.
Professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Eduard Vieta, M.D., Ph.D.
Professor of Psychiatry, Chair, Department of Psychiatry and Psychology, Institute of Neuroscience, University of Barcelona, Hospital Clinic, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
Katherine L. Wisner, M.D., M.S.
Norman and Helen Asher Professor of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology; Director, Asher Center for the Study and Treatment of Depressive Disorders, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Mark Zimmerman, M.D.
Professor of Psychiatry and Human Behavior, Brown University; Director of Outpatient Psychiatry and Partial Hospital Program, Rhode Island Hospital, Providence, Rhode Island

Disclosure of Competing Interests

The following contributors to this book have indicated a financial interest in or other affiliation with a commercial supporter, a manufacturer of a commercial product, a provider of a commercial service, a nongovernmental organization, and/or a government agency, as listed below:
Boris Birmaher, M.D.Research funding: National Institute of Mental Health; Royalties: Lippincott Williams & Wilkins, Random House, UpToDate
Marina Garriga, M.D.Grants and/or consultant/advisor: Centro de Investigación Biomédica en Red de salud Mental (CIBERSAM), FEDER, Ferrer, Instituto de Salud Carlos III, Janssen, Lundbeck
Susan L. McElroy, M.D.Principal investigator or co-investigator on research studies sponsored by: Allergan, Brainsway, Marriott Foundation, Myriad, National Institute of Mental Health, Novo Nordisk, Shire, Sunovion; Consultant or scientific advisory board: Bracket, F. Hoffmann-La Roche, MedAvante, Mitsubishi Tanabe Pharma America, Myriad, Novo Nordisk, Shire, Sunovion; Patents: Inventor on U.S. Patent 6,323,236 B2, Use of Sulfamate Derivatives for Treating Impulse Control Disorders, and along with the patent’s assignee, University of Cincinnati, Cincinnati, Ohio, has received payments from Johnson & Johnson Pharmaceutical Research and Development, L.L.C., which has exclusive rights under the patent
Melvin McInnis, M.D.Research support: National Institute of Mental Health (R21 MH114835), Prechter Bipolar Research Fund, Richard Tam Foundation, University of Michigan Depression Center; the author has consulted with Janssen and Otsuka Pharmaceuticals
Eydie L. Moses-Kolko, M.D.—Site Principal Investigator for Sage Pharmaceuticals trial of brexanolone for treatment of postpartum depression (period of study approximately November 1, 2016, to November 1, 2017)
Ayal Schaffer, M.D., F.R.C.P.C.Research grants: American Foundation for Suicide Prevention; Canadian Institute of Health Research; Ontario Mental Health Foundation; Ontario Ministry of Health and Long-Term Care (IMPACT Award); Honoraria of other fees: Allergan, Asofarma, Lundbeck, Sunovion
Eva Solé, M.D.Grants and/or consultant/advisor: Centro de Investigación Biomédica en Red de salud Mental (CIBERSAM), Instituto de Salud Carlos III
Holly A. Swartz, M.D.Grant support: Myriad Genetics, National Institute of Mental Health; Consultant: Myriad Genetics; Royalties: UpToDate
Eduard Vieta, M.D., Ph.D.Grants and consultant/advisor/CME speaker: AB-Biotics, Actavis, Allergan, AstraZeneca, Bristol-Myers Squibb, Ferrer, Forest Research Institute, Geodon Richter, Glaxo-Smith-Kline, Janssen, Lundbeck, Otsuka, Pfizer, Roche, Sanofi-Aventis, Servier, Shire, Sunovion, Takeda, Telefónica, Brain and Behavior Foundation, Spanish Ministry of Science and Innovation (Centro de Investigación Biomédica en Red de salud Mental; CIBERSAM), Seventh European Framework Programme (ENBREC), Stanley Medical Research Institute
The following contributors to this book have indicated no competing interests to disclose:
Crystal T. Clark, M.D., M.Sc.
Sarah DeBrunner, M.D.
Anna Manelis, Ph.D.
Manivel Rengasamy, M.D.
Trisha Suppes, M.D., Ph.D.

Preface

What is bipolar II disorder? Are there really different types of bipolar disorder? Why does it matter?
Even many experienced clinicians may know surprisingly little about bipolar II disorder. Despite being a common illness, bipolar II disorder is misunderstood, neglected, and rarely receives the attention it deserves. When working with individuals diagnosed with bipolar II disorder, many clinicians have no clear roadmap for identifying or treating the disorder. As a result, bipolar II disorder often goes undiagnosed. Once the disorder is recognized, many clinicians use therapies that were tested in patients with bipolar I disorder to treat bipolar II disorder, even though the latter is quite different from the former. Shared frustrations about how little information is available to professionals about bipolar II disorder led us to write this book with the goal of providing a comprehensive resource for those interested in learning more. We hope it will serve as a resource for clinicians who care for individuals with bipolar II disorder, researchers who study bipolar II disorder, supporters who are concerned about someone with bipolar II disorder, and those who wish to learn more about their own diagnosis. All of these groups will find much to interest them in these chapters; the book, however, is written primarily for professionals rather than a lay audience.
The book is divided into four parts: 1) Recognition, focused on differential diagnosis of bipolar II disorder; 2) Understanding, focused on biology; 3) Treatment, focused on pharmacotherapy and psychotherapy; and 4) Special Populations, focused on bipolar II disorder in youth and women. Individual chapters are written by experts in the fields of phenomenology, genetics, neuroimaging, psychopharmacology, psychotherapy, child psychiatry, and reproductive mental health, who review what is currently known about bipolar II disorder and its management. Throughout the book, readers will find case vignettes illustrating clinical applications of the research literature discussed in each chapter. The main messages of each chapter are summarized as Key Points for easy reference and review.
We are thrilled to see that many advances have been made in understanding bipolar II disorder since the diagnosis was first codified in 1994. We are also humbled by the many holes that remain in the evidence base, particularly related to optimal treatments and neurobiology. This collection of writings highlights not only what we have learned about bipolar II disorder but also how much more we have yet to discover. This book seeks to answer many of the pressing, unresolved questions about bipolar II disorder facing those working in psychiatry. Our greatest hope, however, is that we will spur others to ask even more questions and find even better answers in the future.
Holly A. Swartz, M.D.
Trisha Suppes, M.D., Ph.D.

Information & Authors

Information

Published In

Go to Bipolar II Disorder
Bipolar II Disorder: Recognition, Understanding, and Treatment
Pages: i - xvi

History

Published in print: 17 May 2019
Published online: 5 December 2024
© American Psychiatric Association Publishing

Authors

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Figures

Tables

Media

Share

Share

Share article link

Share